腫瘍アブレーションの世界市場 2024-2028

腫瘍アブレーション市場は2023-2028年に14億3,280万米ドル、予測期間中のCAGRは14.62％で成長すると予測されます。

当レポートでは、腫瘍アブレーション市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、低侵襲治療への嗜好の高まり、個別化医療と標的治療への継続的な重点化、外来でのがん治療への注目の高まりによって牽引されています。

本調査では、今後数年間の腫瘍アブレーション市場成長を牽引する主要因の1つとして、画像誘導腫瘍アブレーションの採用増加を挙げています。また、マルチモーダル腫瘍アブレーションアプローチの開拓や人工知能（AI）の腫瘍アブレーションプラットフォームへの統合は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 腫瘍アブレーションの世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 用途別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 タイプ別市場セグメンテーション

• 市場セグメント
• 比較：タイプ別
• 高周波アブレーション：市場規模と予測 2023-2028
• マイクロ波アブレーション：市場規模と予測 2023-2028
• 凍結療法：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 用途別の市場セグメンテーション

• 市場セグメント
• 比較：用途別
• 肝臓がん：市場規模と予測 2023-2028
• 肺がん：市場規模と予測 2023-2028
• 腎臓がん：市場規模と予測 2023-2028
• 乳房とその他：市場規模と予測 2023-2028
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AngioDynamics Inc.
• Bioventus LLC
• Boston Scientific Corp.
• BVM Medical Ltd.
• EDAP TMS
• ForTec Medical
• Johnson and Johnson Services Inc.
• Medtronic Plc
• Merit Medical Systems Inc.
• Monteris Medical Corp.
• Olympus Europa SE and Co. KG
• Smith and Nephew plc
• Stryker Corp.
• Terumo Corp.
• Varian Medical Systems Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global tumor ablation market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Radiofrequency ablation - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Radiofrequency ablation - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Radiofrequency ablation - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Radiofrequency ablation - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Microwave ablation - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Microwave ablation - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Microwave ablation - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Microwave ablation - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Cryoablation - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Cryoablation - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Cryoablation - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Cryoablation - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits50: Market opportunity by Type ($ million)
• Exhibits51: Data Table on Market opportunity by Type ($ million)
• Exhibits52: Chart on Application - Market share 2023-2028 (%)
• Exhibits53: Data Table on Application - Market share 2023-2028 (%)
• Exhibits54: Chart on Comparison by Application
• Exhibits55: Data Table on Comparison by Application
• Exhibits56: Chart on Liver cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Liver cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Liver cancer - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Liver cancer - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Lung cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Lung cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Lung cancer - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Lung cancer - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Kidney cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Kidney cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Kidney cancer - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Kidney cancer - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Breast and others - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Data Table on Breast and others - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Chart on Breast and others - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Breast and others - Year-over-year growth 2023-2028 (%)
• Exhibits72: Market opportunity by Application ($ million)
• Exhibits73: Data Table on Market opportunity by Application ($ million)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits111: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits112: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits113: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits114: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ million)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits117: Impact of drivers and challenges in 2023 and 2028
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: AngioDynamics Inc. - Overview
• Exhibits124: AngioDynamics Inc. - Business segments
• Exhibits125: AngioDynamics Inc. - Key news
• Exhibits126: AngioDynamics Inc. - Key offerings
• Exhibits127: AngioDynamics Inc. - Segment focus
• Exhibits128: Bioventus LLC - Overview
• Exhibits129: Bioventus LLC - Business segments
• Exhibits130: Bioventus LLC - Key news
• Exhibits131: Bioventus LLC - Key offerings
• Exhibits132: Bioventus LLC - Segment focus
• Exhibits133: Boston Scientific Corp. - Overview
• Exhibits134: Boston Scientific Corp. - Business segments
• Exhibits135: Boston Scientific Corp. - Key news
• Exhibits136: Boston Scientific Corp. - Key offerings
• Exhibits137: Boston Scientific Corp. - Segment focus
• Exhibits138: BVM Medical Ltd. - Overview
• Exhibits139: BVM Medical Ltd. - Product / Service
• Exhibits140: BVM Medical Ltd. - Key offerings
• Exhibits141: EDAP TMS - Overview
• Exhibits142: EDAP TMS - Business segments
• Exhibits143: EDAP TMS - Key offerings
• Exhibits144: EDAP TMS - Segment focus
• Exhibits145: ForTec Medical - Overview
• Exhibits146: ForTec Medical - Product / Service
• Exhibits147: ForTec Medical - Key offerings
• Exhibits148: Johnson and Johnson Services Inc. - Overview
• Exhibits149: Johnson and Johnson Services Inc. - Business segments
• Exhibits150: Johnson and Johnson Services Inc. - Key news
• Exhibits151: Johnson and Johnson Services Inc. - Key offerings
• Exhibits152: Johnson and Johnson Services Inc. - Segment focus
• Exhibits153: Medtronic Plc - Overview
• Exhibits154: Medtronic Plc - Business segments
• Exhibits155: Medtronic Plc - Key news
• Exhibits156: Medtronic Plc - Key offerings
• Exhibits157: Medtronic Plc - Segment focus
• Exhibits158: Merit Medical Systems Inc. - Overview
• Exhibits159: Merit Medical Systems Inc. - Business segments
• Exhibits160: Merit Medical Systems Inc. - Key offerings
• Exhibits161: Merit Medical Systems Inc. - Segment focus
• Exhibits162: Monteris Medical Corp. - Overview
• Exhibits163: Monteris Medical Corp. - Product / Service
• Exhibits164: Monteris Medical Corp. - Key offerings
• Exhibits165: Olympus Europa SE and Co. KG - Overview
• Exhibits166: Olympus Europa SE and Co. KG - Product / Service
• Exhibits167: Olympus Europa SE and Co. KG - Key offerings
• Exhibits168: Smith and Nephew plc - Overview
• Exhibits169: Smith and Nephew plc - Business segments
• Exhibits170: Smith and Nephew plc - Key news
• Exhibits171: Smith and Nephew plc - Key offerings
• Exhibits172: Smith and Nephew plc - Segment focus
• Exhibits173: Stryker Corp. - Overview
• Exhibits174: Stryker Corp. - Business segments
• Exhibits175: Stryker Corp. - Key news
• Exhibits176: Stryker Corp. - Key offerings
• Exhibits177: Stryker Corp. - Segment focus
• Exhibits178: Terumo Corp. - Overview
• Exhibits179: Terumo Corp. - Business segments
• Exhibits180: Terumo Corp. - Key offerings
• Exhibits181: Terumo Corp. - Segment focus
• Exhibits182: Varian Medical Systems Inc. - Overview
• Exhibits183: Varian Medical Systems Inc. - Business segments
• Exhibits184: Varian Medical Systems Inc. - Key offerings
• Exhibits185: Varian Medical Systems Inc. - Segment focus
• Exhibits186: Inclusions checklist
• Exhibits187: Exclusions checklist
• Exhibits188: Currency conversion rates for US$
• Exhibits189: Research methodology
• Exhibits190: Validation techniques employed for market sizing
• Exhibits191: Information sources
• Exhibits192: List of abbreviations

The tumor ablation market is forecasted to grow by USD 1432.8 mn during 2023-2028, accelerating at a CAGR of 14.62% during the forecast period. The report on the tumor ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing preference for minimally invasive procedures, continued emphasis on personalized medicine and targeted therapies, and rising focus on cancer treatment in outpatient settings.

Technavio's tumor ablation market is segmented as below:

By Type

• Radiofrequency ablation
• Microwave ablation
• Cryoablation
• Others

By Application

• Liver cancer
• Lung cancer
• Kidney cancer
• Breast and others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing adoption of image-guided tumor ablation as one of the prime reasons driving the tumor ablation market growth during the next few years. Also, development of multimodal tumor ablation approaches and integration of artificial intelligence (AI) into tumor ablation platforms will lead to sizable demand in the market.

The report on the tumor ablation market covers the following areas:

• Tumor ablation market sizing
• Tumor ablation market forecast
• Tumor ablation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tumor ablation market vendors that include Alpinion Medical Systems Co. Ltd., AngioDynamics Inc., Apyx Medical Corp., Bioventus LLC, Boston Scientific Corp., BVM Medical Ltd., EDAP TMS, ForTec Medical, IceCure Medical Ltd., Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Monteris Medical Corp., Olympus Europa SE and Co. KG, Profound Medical Corp., Smith and Nephew plc, Stryker Corp., TechsoMed Medical Technologies Ltd., Terumo Corp., and Varian Medical Systems Inc.. Also, the tumor ablation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global tumor ablation market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Radiofrequency ablation - Market size and forecast 2023-2028
• 6.4 Microwave ablation - Market size and forecast 2023-2028
• 6.5 Cryoablation - Market size and forecast 2023-2028
• 6.6 Others - Market size and forecast 2023-2028
• 6.7 Market opportunity by Type

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 Liver cancer - Market size and forecast 2023-2028
• 7.4 Lung cancer - Market size and forecast 2023-2028
• 7.5 Kidney cancer - Market size and forecast 2023-2028
• 7.6 Breast and others - Market size and forecast 2023-2028
• 7.7 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 AngioDynamics Inc.
• 12.4 Bioventus LLC
• 12.5 Boston Scientific Corp.
• 12.6 BVM Medical Ltd.
• 12.7 EDAP TMS
• 12.8 ForTec Medical
• 12.9 Johnson and Johnson Services Inc.
• 12.10 Medtronic Plc
• 12.11 Merit Medical Systems Inc.
• 12.12 Monteris Medical Corp.
• 12.13 Olympus Europa SE and Co. KG
• 12.14 Smith and Nephew plc
• 12.15 Stryker Corp.
• 12.16 Terumo Corp.
• 12.17 Varian Medical Systems Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations